TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: wire radiopacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lubricity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 22-hour glycemic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ASAS20 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sleep disturbance improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: clinician-rated social anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean SIT score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically meaningful reduction in SIT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate or severe congestion
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of successfully completed subsequent pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Early infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Time spent in the tight range of 4.4 to 7.8 mmol/L overnight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time spent during the day with hyperglycaemic excursions (glucose >10.0 mmol/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coping with NPS in residents with dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of Motion (ROM) for neck rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of compensatory neck movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average plasma glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: twitch force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cost of cytomegalovirus care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Leukopenia episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained virologic response 12 weeks after treatment end
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accelerometer counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minutes of sedentary activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eradication rate of HP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: naming reaction times (RTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: error rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hospital admission
Endpoint domain: Mortality/survival
Primary endpoint: Relapses
Endpoint domain: Mortality/survival
Primary endpoint: Mean blood flow induced by estradiol‐17 beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Forearm resistance after estradiol‐17 beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: ASCVD risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of secondary ACL injury
Endpoint domain: Mortality/survival
Primary endpoint: normalized knee extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: normalized knee flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adherence to treatment course
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reports of side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Participant-rated severity of treatment-related reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator-reported outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant-reported outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Morning urinary albumin excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Relative power changes in alpha band
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phase coherence of alpha band
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depressive and distress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost-effectiveness advantage for Group CBT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increase in PVC rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of intraarticular glucocorticoid injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in International Prostate Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in flowmetry parameters (Qmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in normal gait patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief from perioral fibrotic bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neointimal hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: major clinical events
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in MMASI evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: diurnal Feno levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dapsone induced haemolysis
Endpoint domain: Adverse events/effects
Primary endpoint: severity of caregiving difficulties
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: KC progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spherical equivalent change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day surgical site infection
Endpoint domain: Adverse events/effects
Primary endpoint: clinically relevant postoperative pancreatic fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in goiter size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of STIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: %RC (Respiratory Compliance)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: pO2 (Partial Pressure of Oxygen)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: accuracy in object recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence in object recognition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Symptom reduction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of Oral Mucositis (OM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: soft tissue health status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall cancer core rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Biopsy related pain level
Endpoint domain: Adverse events/effects
Primary endpoint: Sexual Desire Inventory score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Grades 3 to 4 infections
Endpoint domain: Adverse events/effects
Primary endpoint: Headache type and location
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of 17 hydroxyprogesterone (17OHP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum levels of estradiol (E2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Delta LH increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Occurrence of PVL
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of IVH
Endpoint domain: Adverse events/effects
Primary endpoint: time for laryngoscopy and Intubation Difficulty Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: decrease in night sweats
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of subjects with adequate levels of rabies virus neutralizing antibody (RVNA) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of subjects with antibody titers indicative of seroprotection (PRNT50 titers ≥1:10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Early neurologic deterioration (END) within the first 10 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stroke progression within the first 10 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 6-month disability (measured by Barthel Index and modified Rankin Scale)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Luteal phase length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Luteal P levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: compliance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of incarcerations
Endpoint domain: Adverse events/effects
Primary endpoint: externalizing behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: substance use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: violence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: sexual activity
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Active emptying fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: eradication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: G3-G4 mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Correlation of DTI measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of dropout
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage change from baseline in LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inspired absolute humidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student confidence in managing complications
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Specific to non-specific ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Significant PTSD symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lack of motivation as a barrier
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reporting of barriers by BMI status
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Forced expiratory volumes in 1 second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medication adjustment recommendation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mindfulness facets
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maximal clot strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean reductions in PANSS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of complications (biliary and pancreatic fistulas, wound infections)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean duration of treatment to achieve recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRCS completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body weight changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in volume voided
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: number of voids per 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Left ventricular diastolic function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Antero posterior translation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported frequency of cognitive failures
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: attention/concentration complaints
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline BCVA letter score at month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients who gained > or =15 letters in BCVA at month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean reduction in excess foveal thickness at month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: remission at posttreatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission at 6-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4 lymphocyte suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: geometric miss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of AKI as determined by attenuation of sCr rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Intent to add servings of vegetables
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Intent to add minutes of exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intent to recommend CRC screening
Endpoint domain: Life impact
Endpoint subdomain: Health behavior
Primary endpoint: sunburn rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: sun protection policies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: current tobacco use prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in LDL-C level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC(168)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of appropriate shocks and ATP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of ICD therapies per patient-year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of acute rejection episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of corticosteroid-resistant rejection episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Preoperative prostate volume in TRUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total IPSS score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Displacement of the spinal hardware (DSH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute Kidney Injury (AKI) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Insulin levels post-challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Glucose levels post-challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: underestimation rate for DCIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: no precursor/malignant tissue left after VABB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: hourly number of episodes of central apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percentage of total sleep time spent below an arterial oxyhemoglobin saturation of 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: subjective perception of overall sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Exit-site infection rates
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter survival
Endpoint domain: Mortality/survival
Primary endpoint: Breath hydrogen excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma propionate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma butyrate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of acute dermatolymphangioadenitis episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: DLQI scores (Dermatology Life Quality Index)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: costs of stoma care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ease of abdominal wall closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dermatitis score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 6-minute walk distance (6-MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative workload
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: haematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drainage output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-operative hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 2-year increases in spine BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD gains at the distal radius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of isoprene and decane after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive distortions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Early maladaptive schemas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adaptive thinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Attitudes toward treatment efficacy and self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Screening and counseling skills scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total duration of erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Total duration of edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Overall degree of clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of shock wave treatment for tennis elbow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for additional labor analgesia
Endpoint domain: Adverse events/effects
Primary endpoint: ICU hospital days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Life-sustaining treatments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Delayed initial post-operative demand of analgesic medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse responses to treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Appointment availability for new Medicaid patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of appointments with nonphysician providers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median wait times for new Medicaid patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to ongoing pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative ongoing pregnancy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated mean costs per couple
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of fluid overload
Endpoint domain: Adverse events/effects